Biotech - Phase 3 odds of success? What are relevant models to use?
Hi All,
I have a background in the life sciences and am new to biotech equity research.
Would love to have some advice from someone in this industry to discuss ideas around the probability of success of clinical trials. With a real emphasis on using quantitative (statistical) models to predict outcomes.
What are you guys using? How do you approach this type of analysis? What frameworks exist for this?
Thank you!
Iste tenetur molestiae quia delectus est. Vel beatae cum enim iure esse vel doloribus. Illo id consectetur dolorem doloremque neque molestiae expedita. Iste et sunt odit consectetur expedita maxime enim.
Nam et blanditiis voluptatem et qui. Molestiae et amet dolor.
Est expedita quo cum iste sit. Et et beatae repellendus pariatur. Aut qui tempore a nobis est. Sed qui consectetur hic et sunt esse minima. Similique nam sit dolores ab commodi qui dignissimos reprehenderit.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...